
VEON rose 62.6% from $48.56 to $78.94, ahead of the S&P 500's +11.2%. Its worst day was Mar 12 (−16.8%), and its low came Mar 12 at $44.31.
Nov 17, 2025 – Nov 16, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
VEON shares fell 7.9%, while the S&P 500 rose 0.1%.
−7.9% · S&P 500 +0.1%
EPS of $-0.44 missed the $1.66 estimate on $1.2B revenue (est. $1.1B); FY revenue guidance of $4.8B–$4.9B against the $4.7B consensus.
Story events cover the past 12 months · Times ET
+14.2%, the year's best day, on 688K shares, the year's heaviest volume · S&P 500 −0.6%
EPS of $1.39 beat the $1.29 estimate on $1.2B revenue (est. $1.2B); FY revenue guidance of $4.9B–$5.0B against the $4.9B consensus.
+13.8% · S&P 500 +0.6%
EPS of $1.69 beat the $1.59 estimate on $1.3B revenue (est. $1.2B); FY revenue guidance of $5.1B–$5.2B against the $4.9B consensus.
−0.9% · S&P 500 +0.7%
VEON closed at its highest level of the year, 82.1% above where the year started.
+0.8% · S&P 500 −0.4%
EPS of $2.67 beat the $1.77 estimate on $1.3B revenue (est. $1.3B); FY revenue guidance of $5.1B–$5.2B against the $5.1B consensus.
+3.0% · S&P 500 +0.3%
Where it ended: a close of $78.94 on Nov 16, 2026. Up next: Q4 2026 earnings on Mar 12, 2027 (EPS est. $1.64, revenue est. $1.4B).
Nothing in the past 12 months.
All VEON dividend historyAs of the Nov 16, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for VEON and SPY from Benzinga historical bars. Not investment advice.